Feigin, V. L. et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 20(10), 795–820. https://doi.org/10.1016/S1474-4422(21)00252-0 (2021).
King, D. et al. The future incidence, prevalence and costs of stroke in the UK. Age Ageing 49(2), 277–282. https://doi.org/10.1093/ageing/afz163 (2020).
Kadir, R. R. A. et al. Outgrowth endothelial cell conditioned medium negates TNF-α-evoked cerebral barrier damage: A reverse translational research to explore mechanisms. Stem Cell Rev. Rep. https://doi.org/10.1007/s12015-022-10439-4 (2022).
Ya, J., Kadir, R. R. A. & Bayraktutan, U. Delay of endothelial cell senescence protects cerebral barrier against age-related dysfunction: Role of senolytics and senomorphics. Tissue Barriers 11, 2103353. https://doi.org/10.1080/21688370.2022.2103353 (2022).
Guo, S. et al. Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. Proc. Natl. Acad. Sci. USA 105(21), 7582–7587. https://doi.org/10.1073/pnas.0801105105 (2008).
Kadir, R. R. A., Alwjwaj, M. & Bayraktutan, U. Treatment with outgrowth endothelial cells protects cerebral barrier against ischemic injury. Cytotherapy https://doi.org/10.1016/j.jcyt.2021.11.005 (2022).
Abdulkadir, R. R. et al. Outgrowth endothelial cells form a functional cerebral barrier and restore its integrity after damage. Neural Regen. Res. 15(6), 1071–1078. https://doi.org/10.4103/1673-5374.269029 (2020).
Chambers, S. E. J. et al. Current concepts on endothelial stem cells definition, location, and markers. Stem Cells Transl. Med. 10(S2), S54–S61. https://doi.org/10.1002/sctm.21-0022 (2021).
Alwjwaj, M., Kadir, R. R. A. & Bayraktutan, U. The secretome of endothelial progenitor cells: A potential therapeutic strategy for ischemic stroke. Neural Regen. Res. 16(8), 1483–1489. https://doi.org/10.4103/1673-5374.303012 (2021).
Kadir, R. R. A. et al. Inhibition of oxidative stress delays senescence and augments functional capacity of endothelial progenitor cells. Brain Res. 1787, 147925. https://doi.org/10.1016/j.brainres.2022.147925 (2022).
Kukumberg, M. et al. Characterization and functional assessment of endothelial progenitor cells in ischemic stroke patients. Stem Cell Rev. Rep. https://doi.org/10.1007/s12015-020-10064-z (2020).
Höhn, A. et al. Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence. Redox Biol. 11, 482–501. https://doi.org/10.1016/j.redox.2016.12.001 (2017).
Satoh, M. et al. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 198(2), 347–353. https://doi.org/10.1016/j.atherosclerosis.2007.09.040 (2008).
Rakkar, K. et al. Endothelial progenitor cells, potential biomarkers for diagnosis and prognosis of ischemic stroke: Protocol for an observational case-control study. Neural. Regen. Res. 15(7), 1300–1307. https://doi.org/10.4103/1673-5374.269028 (2020).
Martinez-Majander, N. et al. Endothelial dysfunction is associated with early-onset cryptogenic ischemic stroke in men and with increasing age. J. Am. Heart Assoc. 10(14), e020838. https://doi.org/10.1161/JAHA.121.020838 (2021).
Kadir, R. R. A., Alwjwaj, M. & Bayraktutan, U. MicroRNA: An emerging predictive, diagnostic, prognostic and therapeutic strategy in ischaemic stroke. Cell. Mol. Neurobiol. https://doi.org/10.1007/s10571-020-01028-5 (2020).
Chang, E. I. et al. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1α stabilization during ischemia. Circulation 116(24), 2818–2829. https://doi.org/10.1161/CIRCULATIONAHA.107.715847 (2007).
Rakkar, K. et al. Evaluation of endothelial progenitor cell characteristics as clinical biomarkers for elderly patients with ischaemic stroke. Stem Cell Rev. Rep. https://doi.org/10.1007/s12015-023-10544-y (2023).
Chu, K. et al. Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke. Stroke 39(5), 1441–1447. https://doi.org/10.1161/STROKEAHA.107.499236 (2008).
Bayraktutan, U. Endothelial progenitor cells: Potential novel therapeutics for ischaemic stroke. Pharmacol. Res. 144, 181–191. https://doi.org/10.1016/j.phrs.2019.04.017 (2019).
Camps-Renom, P. et al. Endothelial progenitor cells count after acute ischemic stroke predicts functional outcome in patients with carotid atherosclerosis. J. Stroke Cerebrovasc. Dis. 30(12), 106144. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106144 (2021).
Gardener, H. et al. Functional status at 30 and 90 days after mild ischaemic stroke. Stroke Vasc. Neurol. 7(5), 375–380. https://doi.org/10.1136/svn-2021-001333 (2022).
Pelosi, E. et al. Identification of the hemangioblast in postnatal life. Blood 100(9), 3203–3208. https://doi.org/10.1182/blood-2002-05-1511 (2002).
Popa, E. R. et al. Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo. J. Mol. Cell Cardiol. 41(1), 86–96. https://doi.org/10.1016/j.yjmcc.2006.04.021 (2006).
Peichev, M. et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95(3), 952–958 (2000).
Rossi, E. et al. Human endothelial colony forming cells express intracellular CD133 that modulates their vasculogenic properties. Stem Cell Rev. Rep. 15(4), 590–600. https://doi.org/10.1007/s12015-019-09881-8 (2019).
Abumiya, T. et al. Activated microvessels express vascular endothelial growth factor and integrin alpha(v)beta3 during focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19(9), 1038–1050. https://doi.org/10.1097/00004647-199909000-00012 (1999).
Di Santo, S. et al. Novel cell-free strategy for therapeutic angiogenesis: In vitro generated conditioned medium can replace progenitor cell transplantation. PLoS ONE 4(5), e5643. https://doi.org/10.1371/journal.pone.0005643 (2009).
Lin, T. N. et al. Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion. Stroke 34(1), 177–186. https://doi.org/10.1161/01.str.0000047100.84604.ba (2003).
Skovseth, D. K. et al. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood 105(3), 1044–1051. https://doi.org/10.1182/blood-2004-03-1164 (2005).
Ji, W. R. et al. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. Faseb J. 12(15), 1731–1738. https://doi.org/10.1096/fasebj.12.15.1731 (1998).
Zhang, C. et al. Endostatin as a novel prognostic biomarker in acute ischemic stroke. Atherosclerosis 293, 42–48. https://doi.org/10.1016/j.atherosclerosis.2019.11.032 (2020).
Abdullah, Z. & Bayraktutan, U. NADPH oxidase mediates TNF-α-evoked in vitro brain barrier dysfunction: Roles of apoptosis and time. Mol. Cell Neurosci. 61, 72–84. https://doi.org/10.1016/j.mcn.2014.06.002 (2014).
Allen, C. L. & Bayraktutan, U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int. J. Stroke 4(6), 461–470. https://doi.org/10.1111/j.1747-4949.2009.00387.x (2009).
Ülker, S., McKeown, P. P. & Bayraktutan, U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41(3), 534–539. https://doi.org/10.1161/01.HYP.0000057421.28533.37 (2003).
Ulker, S. et al. Antioxidant vitamins C and E ameliorate hyperglycaemia-induced oxidative stress in coronary endothelial cells. Diabetes Obes. Metab. 6(6), 442–451. https://doi.org/10.1111/j.1462-8902.2004.00443.x (2004).
He, T., Joyner, M. J. & Katusic, Z. S. Aging decreases expression and activity of glutathione peroxidase-1 in human endothelial progenitor cells. Microvasc. Res. 78(3), 447–452. https://doi.org/10.1016/j.mvr.2009.08.009 (2009).
Liu, Y. et al. Proteomic analysis of endothelial progenitor cells exposed to oxidative stress. Int. J. Mol. Med. 32(3), 607–614. https://doi.org/10.3892/ijmm.2013.1419 (2013).
Wang, C. et al. MeCP2 mediated dysfunction in senescent EPCs. Oncotarget 8(45), 78289–78299 (2017).
Xia, W. H. et al. Age-related decline in reendothelialization capacity of human endothelial progenitor cells is restored by shear stress. Hypertension 59(6), 1225–1231. https://doi.org/10.1161/HYPERTENSIONAHA.111.179820 (2012).
Capillo, M. et al. Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors. Clin. Cancer Res. 9(1), 377 (2003).
Meijles, D. N. et al. The matricellular protein TSP1 promotes human and mouse endothelial cell senescence through CD47 and Nox1. Sci. Signal. 10(501), 1784. https://doi.org/10.1126/scisignal.aaj1784 (2017).
Cun, Y. et al. Role of the stromal cell derived factor-1 in the biological functions of endothelial progenitor cells and its underlying mechanisms. Exp. Ther. Med. 21(1), 39. https://doi.org/10.3892/etm.2020.9471 (2021).
Churdchomjan, W. et al. Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control. BMC Endocr. Disord. 10(1), 5. https://doi.org/10.1186/1472-6823-10-5 (2010).
Fadini, G. P. et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile. Arterioscler. Thromb. Vasc. Biol. 28(5), 997–1004. https://doi.org/10.1161/ATVBAHA.107.159558 (2008).
Deng, Y. et al. Mobilization of endothelial progenitor cell in patients with acute ischemic stroke. Neurol. Sci. 39(3), 437–443. https://doi.org/10.1007/s10072-017-3143-y (2018).
Sahebkar, A. et al. Does statin therapy reduce plasma VEGF levels in humans? A systematic review and meta-analysis of randomized controlled trials. Metabolism 64(11), 1466–1476. https://doi.org/10.1016/j.metabol.2015.08.002 (2015).
Sodha, N. R. et al. Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formation. Am. J. Physiol. Heart Circ. Physiol. 296(2), H428-434. https://doi.org/10.1152/ajpheart.00283.2008 (2009).
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.nature.com/articles/s41598-023-48907-7